GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to ...
GSK PLC 10 June 2024 Issued: 10 June 2024, London UK Statement: Zantac (ranitidine) litigation - Kasza case GSK plc (LSE/NYSE: GSK...
GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its re ...
GSK PLC 10 June 2024 Issued: 7 June 2024, London UK US FDA approves expanded age indication for GSK's Arexvy, the first respiratory...
GSK PLC 03 June 2024 GSK plc Total Voting Rights and Capital In conformity with the Financial Conduct Authority's Disclosure Guidance and...
An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it ...
GSK PLC 03 June 2024 Issued: 3 June 2024, London UK Jemperli (dostarlimab) trial continues to show unprecedented results with no evidence of...
GSK PLC on Monday said it will appeal a US court ruling that it should face jury trials relating to cases concerning ...
GSK PLC 03 June 2024 Issued: 2 June 2024, London UK Blenrep combination reduced the risk of disease progression or death by nearly 50...
GSK PLC 03 June 2024 Issued: 1 June 2024, London UK Statement: Zantac (ranitidine) litigation - Delaware State Court Daubert Ruling · ...
GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.